Robert Bruce's LVTX Position Overview
Robert Bruce (via Bruce & Co., Inc.) currently holds 521.9K shares of LAVA Therapeutics N.V. (LVTX) worth $0, representing 0.00% of the portfolio. First purchased in 2022-Q4, this medium-term investment has been held for 12 quarters.
Based on 13F filings, Robert Bruce has maintained a strategic position in LVTX, demonstrating sustained confidence in this investment. Largest addition occurred in Q1 2023, adding 571.9K shares. Largest reduction occurred in Q1 2025, reducing 250.0K shares.
Analysis based on 13F filings available since 2013 Q2
Robert Bruce's LAVA Therapeutics NV (LVTX) Holding Value Over Time
Track share changes against reported price movement
Quarterly LAVA Therapeutics NV (LVTX) Trades by Robert Bruce
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2022 | +100,000 | New Buy | 100,000 | $3.50 |
| Q1 2023 | +571,874 | Add 571.87% | 671,874 | $1.66 |
| Q2 2023 | +100,000 | Add 14.88% | 771,874 | $2.03 |
| Q1 2025 | -250,000 | Reduce 32.39% | 521,874 | $1.27 |
| Q3 2025 | -521,874 | Sold Out | 521,874 | $0.00 |
Robert Bruce's LAVA Therapeutics NV Investment FAQs
Robert Bruce first purchased LAVA Therapeutics N.V. (LVTX) in Q4 2022, acquiring 100,000 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Robert Bruce has held LAVA Therapeutics N.V. (LVTX) for 12 quarters since Q4 2022. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Robert Bruce's largest addition to LAVA Therapeutics N.V. (LVTX) was in Q1 2023, adding 671,874 shares worth $1.12 M. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
According to the latest 13F filing for Q3 2025, Robert Bruce's firm, Bruce & Co., Inc., owns 521,874 shares of LAVA Therapeutics N.V. (LVTX), valued at approximately $0. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
As of the Q3 2025 filing, LAVA Therapeutics N.V. (LVTX) represents approximately 0.00% of Robert Bruce's publicly disclosed stock portfolio, making it one of their key holdings. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Robert Bruce's peak holding in LAVA Therapeutics N.V. (LVTX) was 771,874 shares, as reported at the end of Q2 2023. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.